Correlation Between Inhibikase Therapeutics and Pmv Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Inhibikase Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Pmv Pharmaceuticals.
Diversification Opportunities for Inhibikase Therapeutics and Pmv Pharmaceuticals
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Inhibikase and Pmv is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Pmv Pharmaceuticals
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 2.34 times more return on investment than Pmv Pharmaceuticals. However, Inhibikase Therapeutics is 2.34 times more volatile than Pmv Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 182.00 in Inhibikase Therapeutics on September 2, 2024 and sell it today you would earn a total of 110.00 from holding Inhibikase Therapeutics or generate 60.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Pmv Pharmaceuticals
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Pmv Pharmaceuticals |
Inhibikase Therapeutics and Pmv Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Pmv Pharmaceuticals
The main advantage of trading using opposite Inhibikase Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |